Ligand validation:2VCI

2GJ: 5-[2,4-DIHYDROXY-5-(1-METHYLETHYL)PHENYL]-N-ETHYL-4-[4-(MORPHOLIN-4-YLMETHYL)PHENYL]ISOXAZOLE-3-CARBOXAMIDE

2GJ is a Ligand Of Interest in 2VCI designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2VCI_2GJ_A_1225	46%	19%	0.177	0.911	0.96	2.44	1	13	3	0	100%	1
6LTI_2GJ_A_301	78%	17%	0.097	0.939	2.17	1.45	4	6	0	0	100%	1
6CJS_2GJ_A_301	63%	29%	0.145	0.94	1.4	1.43	2	6	0	0	100%	1
7K9S_2GJ_A_301	19%	4%	0.295	0.89	4	1.76	20	9	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.